Tertiary-care management of TB/HIV co-infection in Port Harcourt, Nigeria: A retrospective cohort analysis

ABSTRACT Background Monitoring the treatment of tuberculosis(TB) and human immunodeficiency virus(HIV) co-infection is very important to improve patient management and compliance. This study assessed the treatment outcomes of registered TB/HIV co-infected patients enrolled in the Directly Observed Treatment Short course(DOTS) program. Methods A retrospective study was conducted in a tertiary-care hospital in Port Harcourt, Nigeria from January 1, 2014 to December 31, 2019. Data were extracted from the National TB program register and analyzed using the statistical software package(IBM SPSS version30.0). Bivariate and multivariate logistic regressions were used to identify factors associated with treatment outcomes at 95% confidence intervals. Results Among 305(37.4%) TB/HIV co-infected patients, the mean age was 29.2years, with 29.8% in the 0-14 age group, 89.5% new cases, and 89.2% pulmonary TB(PTB) cases. Males(50.2%) slightly outnumbered females(49.8%). Antiretroviral therapy(ART) and cotrimoxazole preventive therapy(CPT) uptake were high(95.1% and 93.4%, respectively). Treatment outcomes were: 19.0% cured, 23.3% completed treatment, 0.3% failed treatment, 23.6% died, 14.8% lost to follow-up, 10.8% transferred out, and 8.2% not evaluated. Overall, treatment success rate was 52.2%. Age(15-24 years: AOR=6.35, 95%CI:1.56-25.86; 25-34 years: AOR=3.97, 95%CI:1.37-11.45; and 45-54 years: AOR=6.40, 95%CI:2.27-18.06) and alternative diagnostic method(AOR=0.32, 95%CI:0.12-0.76) were significantly associated with unsuccessful treatment outcomes. Conclusion The treatment success rate of TB/HIV co-infected patients was relatively low and fell below the WHO target despite high uptake of ART and CPT. Study underscores the need for integrating targeted interventions, including alternative diagnostic methods, into clinical practice and policy to improve treatment outcomes among TB/HIV co-infected patients, particularly in specific age groups.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-08-18
DOI
https://doi.org/10.1371/journal.pone.0325868
Primary Topic
HIV/AIDS Impact and Responses
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tertiary-care management of TB/HIV co-infection in Port Harcourt, Nigeria: A retrospective cohort analysis

Inumanye N. Ojule, A. T. O. Awopeju, Prince Chinonso Nnadozie, Sylva C. Nnadozie
1 links
PLoS ONE
HIV/AIDS Impact and Responses
article

Tertiary-care management of TB/HIV co-infection in Port Harcourt, Nigeria: A retrospective cohort analysis

Inumanye N. Ojule, A. T. O. Awopeju, Prince Chinonso Nnadozie, Sylva C. Nnadozie
article en

Abstract

ABSTRACT Background Monitoring the treatment of tuberculosis(TB) and human immunodeficiency virus(HIV) co-infection is very important to improve patient management and compliance. This study assessed the treatment outcomes of registered TB/HIV co-infected patients enrolled in the Directly Observed Treatment Short course(DOTS) program. Methods A retrospective study was conducted in a tertiary-care hospital in Port Harcourt, Nigeria from January 1, 2014 to December 31, 2019. Data were extracted from the National TB program register and analyzed using the statistical software package(IBM SPSS version30.0). Bivariate and multivariate logistic regressions were used to identify factors associated with treatment outcomes at 95% confidence intervals. Results Among 305(37.4%) TB/HIV co-infected patients, the mean age was 29.2years, with 29.8% in the 0-14 age group, 89.5% new cases, and 89.2% pulmonary TB(PTB) cases. Males(50.2%) slightly outnumbered females(49.8%). Antiretroviral therapy(ART) and cotrimoxazole preventive therapy(CPT) uptake were high(95.1% and 93.4%, respectively). Treatment outcomes were: 19.0% cured, 23.3% completed treatment, 0.3% failed treatment, 23.6% died, 14.8% lost to follow-up, 10.8% transferred out, and 8.2% not evaluated. Overall, treatment success rate was 52.2%. Age(15-24 years: AOR=6.35, 95%CI:1.56-25.86; 25-34 years: AOR=3.97, 95%CI:1.37-11.45; and 45-54 years: AOR=6.40, 95%CI:2.27-18.06) and alternative diagnostic method(AOR=0.32, 95%CI:0.12-0.76) were significantly associated with unsuccessful treatment outcomes. Conclusion The treatment success rate of TB/HIV co-infected patients was relatively low and fell below the WHO target despite high uptake of ART and CPT. Study underscores the need for integrating targeted interventions, including alternative diagnostic methods, into clinical practice and policy to improve treatment outcomes among TB/HIV co-infected patients, particularly in specific age groups.

PLoS ONEVol. 21(8)
Norwegian University of Science and Technology (NO), Infectious Diseases Society of America (US), University of Port Harcourt Teaching Hospital (NG), Trondheim Kommune (NO), University of Bergen (NO)
Universitetet i Bergen, Center for International Health
Openalex Percentile: Top 99%
HIV/AIDS Impact and Responses
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.